iRhythm Holdings (IRTC) Preferred Stock Liabilities (2015 - 2016)

iRhythm Holdings' (IRTC) quarterly Preferred Stock Liabilities came in at $97.1 million in Q3 2016, little changed on a QoQ basis from $97.1 million in Q4 2015.

iRhythm Holdings (IRTC) Preferred Stock Liabilities (2015 - 2016) Analysis & Trends

iRhythm Holdings (IRTC) has 2 years of Preferred Stock Liabilities data on file, last reported at $97.1 million in Q3 2016.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $97.1 million in Q3 2016; TTM through Sep 2016 was $97.1 million, a N/A change from a year earlier, with the FY2015 full-year figure at $97.1 million, up 14.21% from the prior year.
  • Preferred Stock Liabilities for Q3 2016 stood at $97.1 million, roughly flat from $97.1 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for IRTC reached as high as $97.1 million in Q4 2015 and fell as low as $97.1 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 iRhythm Holdings 3.50 Bn 2.95 Bn 141.35 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2016 97.10 Mn
Dec 31, 2015 97.10 Mn